BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18221087)

  • 21. Fibroblast growth factor signaling and inhibition in non-small cell lung cancer and their role in squamous cell tumors.
    Salgia R
    Cancer Med; 2014 Jun; 3(3):681-92. PubMed ID: 24711160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibroblast growth factors, their receptors and signaling.
    Powers CJ; McLeskey SW; Wellstein A
    Endocr Relat Cancer; 2000 Sep; 7(3):165-97. PubMed ID: 11021964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The FGF/FGFR system in the physiopathology of the prostate gland.
    Giacomini A; Grillo E; Rezzola S; Ribatti D; Rusnati M; Ronca R; Presta M
    Physiol Rev; 2021 Apr; 101(2):569-610. PubMed ID: 32730114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast growth factors: at the heart of angiogenesis.
    Slavin J
    Cell Biol Int; 1995 May; 19(5):431-44. PubMed ID: 7543787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small-molecule inhibitors of fibroblast growth factor receptor (FGFR) tyrosine kinases (TK).
    Manetti F; Botta M
    Curr Pharm Des; 2003; 9(7):567-81. PubMed ID: 12570804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of fibroblast growth factors in vascular development.
    Javerzat S; Auguste P; Bikfalvi A
    Trends Mol Med; 2002 Oct; 8(10):483-9. PubMed ID: 12383771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FGF-FGFR Mediates the Activity-Dependent Dendritogenesis of Layer IV Neurons during Barrel Formation.
    Huang JY; Lynn Miskus M; Lu HC
    J Neurosci; 2017 Dec; 37(50):12094-12105. PubMed ID: 29097598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibroblast growth factors and their receptors in cancer.
    Wesche J; Haglund K; Haugsten EM
    Biochem J; 2011 Jul; 437(2):199-213. PubMed ID: 21711248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FGFs, heparan sulfate and FGFRs: complex interactions essential for development.
    Ornitz DM
    Bioessays; 2000 Feb; 22(2):108-12. PubMed ID: 10655030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting fibroblast growth factor pathways in endometrial cancer.
    Winterhoff B; Konecny GE
    Curr Probl Cancer; 2017; 41(1):37-47. PubMed ID: 28041631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of fibroblast growth factor signaling during lens fiber cell differentiation.
    Huang JX; Feldmeier M; Shui YB; Beebe DC
    Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):680-90. PubMed ID: 12556399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of vascular development by fibroblast growth factors.
    Auguste P; Javerzat S; Bikfalvi A
    Cell Tissue Res; 2003 Oct; 314(1):157-66. PubMed ID: 12851809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibroblast growth factors and their receptors: an information network controlling tissue growth, morphogenesis and repair.
    Fernig DG; Gallagher JT
    Prog Growth Factor Res; 1994; 5(4):353-77. PubMed ID: 7780086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate.
    Ittman M; Mansukhani A
    J Urol; 1997 Jan; 157(1):351-6. PubMed ID: 8976296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach.
    Presta M; Chiodelli P; Giacomini A; Rusnati M; Ronca R
    Pharmacol Ther; 2017 Nov; 179():171-187. PubMed ID: 28564583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular signaling by fibroblast growth factor receptors.
    Eswarakumar VP; Lax I; Schlessinger J
    Cytokine Growth Factor Rev; 2005 Apr; 16(2):139-49. PubMed ID: 15863030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition.
    Cross MJ; Claesson-Welsh L
    Trends Pharmacol Sci; 2001 Apr; 22(4):201-7. PubMed ID: 11282421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FGFR a promising druggable target in cancer: Molecular biology and new drugs.
    Porta R; Borea R; Coelho A; Khan S; Araújo A; Reclusa P; Franchina T; Van Der Steen N; Van Dam P; Ferri J; Sirera R; Naing A; Hong D; Rolfo C
    Crit Rev Oncol Hematol; 2017 May; 113():256-267. PubMed ID: 28427515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the fibroblast growth factor receptor family in cancer.
    Hallinan N; Finn S; Cuffe S; Rafee S; O'Byrne K; Gately K
    Cancer Treat Rev; 2016 May; 46():51-62. PubMed ID: 27109926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insights into the role of heparan sulphate in fibroblast growth factor signalling.
    Harmer NJ
    Biochem Soc Trans; 2006 Jun; 34(Pt 3):442-5. PubMed ID: 16709182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.